ProClinical Life Sciences Recruitment Blog

What will be the biggest therapy areas in 2022?

Posted by Monique Ellis

17/01/18 16:15

Which are the therapy areas to watch over the next few years? How will long-standing sectors like oncology and vaccines stand compared with figures in 2017? With some therapy areas forecasted to grow in strength year on year, sales in other areas are expected to slow or stagnate. Have a look at which therapies are likely to be on top by 2022: 

Read More

Topics: Life sciences news

Top 10 most significant FDA approvals of 2017

Posted by Monique Ellis

20/12/17 15:30

Taking a look back over the year, ProClinical reviews the most significant drug and device approvals by the US Food & Drug Association (FDA) in 2017. Giving a healthy 41 products the seal of approval, the FDA has commissioned a variety of novel therapies and innovative devices that are sure to have a big impact within the industry.

Read More

Topics: Life sciences news, Top 10 blog

What will happen if you don’t comply with the MDR and IVDR?

Posted by Owen Bach

07/12/17 12:30

Simply put, failing to comply with the new medical device (MDR) and in-vitro diagnostic (IVDR) regulations is not an option for companies that wish to continue developing these devices once the transitional period comes to an end in 2021. The regulations are absolutely critical to the future success of medical devices companies. Here’s why:

Read More

Topics: Life sciences news, Regulatory affairs, Quality Assurance, Manufacturing

How will the changing role of Notified Bodies after the MDR and IVDR affect your company?

Posted by Owen Bach

30/11/17 12:30

Perhaps one of the most significant changes from the recent EU medical device regulations is the reformed role of Notified Bodies. Previously seen as ‘industry partners’ that would assist medical device companies with compliance and conformity assessments, Notified Bodies will now be the primary enforcers of the new regulations. This is an effort to ensure that they are fully qualified to oversee certified products, and that more emphasis is put on high-risk devices.

Read More

Topics: Life sciences news, Regulatory affairs, Quality Assurance, Manufacturing

Why the Netherlands is a great fit for the European Medicines Agency (EMA)

Posted by Amber Lakeman

29/11/17 16:50

At the end of November 2017, 27 EU member states voted to relocate the London-based European Medicines Agency (EMA) to Amsterdam, following the UK’s decision to leave the EU in 2016. Here’s a glance into why the move to the Netherlands is a good fit for the EMA.

Read More

Topics: Life sciences news

What is the new classification system for medical devices and IVDs following the MDR and IVDR?

Posted by Owen Bach

29/11/17 12:00

In May 2017, the European Parliament published a set of regulations for medical devices (MDR) and in-vitro diagnostics (IVDR) that will require companies to make significant changes to their manufacturing, clinical investigation, quality assurance and data reporting processes. To read more about these transformative pieces of legislation, download our comprehensive guide. This article will explore the impact of the new classification system, for manufacturers of both medical devices and IVDs.

Read More

Topics: Life sciences news, Regulatory affairs, Quality Assurance, Manufacturing

What you need to know about the changes to EU medical devices (MDR) and in-vitro diagnostics (IVDR) regulations (2017)

Posted by Owen Bach

28/11/17 15:30

The new EU medical device and in-vitro diagnostic regulations are an effort by the European Parliament and Council to improve the manufacture and marketing processes of medical devices to ultimately ensure greater patient safety.

Read More

Topics: Life sciences news, Regulatory affairs, Quality Assurance, Manufacturing

What is immuno-oncology? Uncovering the future of cancer therapy

Posted by Monique Ellis

20/09/17 15:30

Hailed as one of the most exciting and unique cancer treatments of today, here’s everything you need to know about this medical marvel.

Read More

Topics: Life sciences news, Clinical research

Top CRO mergers and acquisitions of 2017

Posted by Monique Ellis

13/09/17 15:30

2017 has been quite the year for contract research organisations (CROs), with several significant mergers and acquisitions marking the fast-growing trend of CRO consolidation within the pharmaceutical industry.

Read More

Topics: Life sciences news

The most successful cancer drugs in 2017

Posted by Monique Ellis

26/07/17 15:30

As many as 1,688,780 people in the US alone expect to be diagnosed with cancer this year, leading to an unprecedented and skyrocketing demand for better oncology drugs and treatments. Cancer is one of the most feared diagnosis among patients, with over 200 types of the disease as it can affect almost every organ or tissue in the body.

Read More

Topics: Life sciences news, Clinical research, Top 10 blog, Top 10 list

About this blog

ProClinical is one of the leading recruitment agencies in the life sciences sector. Blogs are written by ProClinical recruitment consultants and experts within the recruitment and life sciences industries. This blog features advice on finding new jobs and career planning, as well as life sciences news and hiring tips for employers.

Subscribe to Email Updates

Recent Posts